0001104659-22-112533.txt : 20221028 0001104659-22-112533.hdr.sgml : 20221028 20221028170850 ACCESSION NUMBER: 0001104659-22-112533 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221027 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221028 DATE AS OF CHANGE: 20221028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Assertio Holdings, Inc. CENTRAL INDEX KEY: 0001808665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850598378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39294 FILM NUMBER: 221342846 BUSINESS ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: (224) 419-7106 MAIL ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 8-K 1 tm2229103d1_8k.htm FORM 8-K
0001808665 false 0001808665 2022-10-27 2022-10-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)
October 28, 2022 (October 27, 2022)

 

 

 

ASSERTIO HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39294   85-0598378
(State or other jurisdiction of
incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 

100 South Sanders Rd., Suite 300,
Lake Forest, IL 60045

(Address of principal executive offices, including zip code)

 

(224) 419-7106

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s):   Name of each exchange on which registered:
Common Stock, $0.0001 par value  

ASRT

   The Nasdaq Stock Market LLC

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

¨     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth Company         ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ¨

 

 

 

 

 

 

Item 8.01 Other Events.

 

On October 27, 2022, Assertio Holdings, Inc. (the “Company”) issued a press release announcing the closing of a transaction to acquire an exclusive license for Sympazan® (clobazam) oral film from Aquestive Therapeutics, Inc. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

Forward Looking Statements

 

Statements in this communication that are not historical facts are forward-looking statements that reflect the Company’s current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, the completion of the offering and the expected amount and intended use of the net proceeds. All statements other than historical facts may be forward-looking statements and can be identified by words such as “anticipate,” “believe,” “could,” “design,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may”, “objective,” “opportunity,” “outlook,” “plan,” “position,” “potential,” “predict,” “project,” “prospective,” “pursue,” “seek,” “should,” “strategy,” “target,” “would,” “will,” “aim” or other similar expressions that convey the uncertainty of future events or outcomes and are used to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of the Company, including the risks described in the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”) and in other filings the Company makes with the SEC from time to time.

 

Investors and potential investors are urged not to place undue reliance on forward-looking statements in this communication, which speak only as of this date. While the Company may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to update or revise any forward-looking-statements contained in this communication whether as a result of new information or future events, except as may be required by applicable law. Nothing contained herein constitutes or will be deemed to constitute a forecast, projection or estimate of the future financial performance or expected results of the Company.

 

Item 9.01 Financial Statements and Exhibits

 

(d)Exhibits

 

  Exhibit Number Description
     
  99.1 Assertio Holdings, Inc. Press Release issued on October 27, 2022
     
  104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: October 28, 2022

 

  ASSERTIO HOLDINGS, INC.
   
  /s/ Dan Peisert
  Dan Peisert
  President and Chief Executive Officer

 

 

 

 EX-99.1 2 tm2229103d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

Assertio Holdings, Inc. Signs Exclusive License for Sympazan® (clobazam) Oral Film from Aquestive Therapeutics, Inc.

 

Trailing 12 Month Revenues of Sympazan Were $9.5 Million

Assertio Paid $9.0 Million Upfront, Additional $6.0 Million upon Patent Allowance

 

LAKE FOREST, IL. – October 27, 2022 – Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced a transaction to acquire an exclusive license for Sympazan® (clobazam) oral film from Aquestive Therapeutics, Inc. (“Aquestive”) (Nasdaq: AQST), a pharmaceutical company advancing current standards of care to solve patients’ problems through simplifying complex delivery methods. The transaction was made through a subsidiary of the Company.

 

“Sympazan fits perfectly with our non-personal digital platform and growth plans, further diversifies our portfolio and brings with it opportunities to significantly extend patent life,” said Dan Peisert, President and Chief Executive Officer of Assertio. “Sympazan can offer benefits to its prescribed population, such as dosing through its oral film technology. For many LGS patients, severely restricted carbohydrate diets, such as keto, are an important treatment approach. Unlike other forms of clobazam, Sympazan has very low carbohydrate content, which aligns to this important treatment recommendation.”

 

Under the terms of the definitive agreement, Assertio acquired an exclusive license for the Sympazan intellectual property from Aquestive for an upfront payment of $9.0 million. Assertio also entered into a long-term supply agreement with Aquestive for Sympazan. Additionally, Aquestive will continue to prosecute an existing patent application that could extend patent coverage to as late as 2039. Upon patent allowance, which Assertio believes will occur in 2023, Assertio will pay a $6.0 million milestone payment and royalties to Aquestive.

 

The Company will provide the expected contribution from Sympazan and an update on its 2022 Guidance on its quarterly earnings call in early November. On a full year basis, Assertio expects that Sympazan will add $4.0 - $4.5 million in adjusted EBITDA and $0.05 in adjusted EPS on a fully diluted basis.

 

“We’re making significant progress towards our business development goals through the completion of both the Otrexup and now Sympazan acquisitions in the last 11 months,” said Peisert. “We believe Sympazan can add approximately 20 percent of the remaining goal to acquire $40 million in gross profit by 2024. Our business development pipeline remains robust with a number of additional opportunities to further deploy our balance sheet capital into new cash flow generating assets.

 

About Sympazan

 

Trade Name Sympazan® (clobazam) oral film formulation
Indication For the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients aged 2 years of age or older
Last to Expire Orange Book Listed Patent April 2024, with potential from filed patent application to extend intellectual property to as late as 2039
Trailing 12 Months Revenue Ended 6/30/22 Approximately $9.5 Million

 

 

 

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS

 

• Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation.

• The use of benzodiazepines, including SYMPAZAN, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Before prescribing SYMPAZAN and throughout treatment, assess each patient’s risk for abuse, misuse, and addiction.

• Abrupt discontinuation or rapid dosage reduction of SYMPAZAN after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue SYMPAZAN.

 

Important Safety Information

 

SYMPAZAN is a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system (CNS) depressants (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma, and death.

 

Get emergency help right away if any of the following happens:

 

·shallow or slowed breathing
·breathing stops (which may lead to the heart stopping)
·excessive sleepiness (sedation)

 

Do not drive or operate heavy machinery until you know how taking SYMPAZAN with opioids affects you.

 

Please see full Prescribing Information including Boxed Warning on risks from concomitant use with opioids; abuse, misuse and addiction; and dependence and withdrawal reactions at www.sympazan.com/pdfs/pi.pdf

 

About Assertio

 

Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more about Assertio, visit www.assertiotx.com.

 

Investor Contact

 

Matt Kreps

Managing Director

Darrow Associates

Austin, TX

M: 214-597-8200

mkreps@darrowir.com

 

 

 

Forward Looking Statements

 

Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio's current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of Assertio, including our ability to realize the benefits from our operating model, successfully acquire and integrate new assets including Sympazan and explore new business development initiatives, as well as Aquestive’s ability to successfully prosecute the pending patent application and timing of allowance by the USPTO. All statements other than historical facts may be forward-looking statements and can be identified by words such as "anticipate," "believe," "could," "design," "estimate," "expect," "forecast," "goal," "guidance," "imply," "intend," "may", "objective," "opportunity," "outlook," "plan," "position," "potential," "predict," "project," "prospective," "pursue," "seek," "should," "strategy," "target," "would," "will," "aim" or other similar expressions that convey the uncertainty of future events or outcomes and are used to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of Assertio, including the risks described in Assertio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission ("SEC") and in other filings Assertio makes with the SEC from time to time. Investors and potential investors are urged not to place undue reliance on forward-looking statements in this communication, which speak only as of this date. While Assertio may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to update or revise any forward-looking-statements contained in this press release whether as a result of new information or future events, except as may be required by applicable law. Nothing contained herein constitutes or will be deemed to constitute a forecast, projection or estimate of the future financial performance or expected results of Assertio.

 

Non-GAAP Financial Measures

 

This release includes estimated non-GAAP adjusted EBITDA and adjusted earnings per share information, which the Company believes enables investors to better understand the anticipated performance of the business, but should be considered a supplement to, and not as a substitute for or superior to, financial measures calculated in accordance with GAAP. No reconciliation of estimated non-GAAP adjusted EBITDA and adjusted earnings per share to estimated net income and estimated earnings per share, respectively, is provided in this release because some of the information necessary for estimated net income such as income taxes, fair value change in contingent consideration, and stock-based compensation is not yet ascertainable or accessible and the Company is unable to quantify these amounts that would be required to be included in estimated net income without unreasonable efforts.

 

Specified Items

 

Non-GAAP measures presented within this release exclude specified items. The Company considers specified items to be significant income/expense items not indicative of current operations. Specified items include adjustments to interest expense, income tax expense (benefit), depreciation expense, amortization expense, sales reserves adjustments for products the Company is no longer selling, stock-based compensation expense, fair value adjustments to contingent consideration, restructuring costs, amortization of fair value inventory step-up as result of purchase accounting, transaction-related costs, gains or losses from adjustments to long-lived assets and assets not part of current operations, and gains or losses resulting from debt refinancing or extinguishment.

 

 EX-101.SCH 3 asrt-20221027.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 asrt-20221027_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 asrt-20221027_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2229103d1_ex99-1img001.jpg GRAPHIC begin 644 tm2229103d1_ex99-1img001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# H'!PD'!@H)" D+"PH,#QD0#PX. M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_ MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T] M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P 1" K *P# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#V:BBB@ I* M6L7Q)K9TBR5;=?,OK@^7;QCDECW^@II7$W97-FBN5T#4;[3=0_L;7)-\\@\R MWG)R),]5SZ@UU6:&K"C*Z%HI*,TBA:*2B@!:*2B@!:*3-&: %HI*,T +129H MS0 M%)1F@!:*** "F22+&C.Y 51DD]A3Z0C/6@##3QEHL@D,=YN\M"[81AP/ ME;L# MQTK<$2 !% P!CH*'=1]WN7LO@^:>U93J$(593""V!GEAD>GY5U/EK_ '5_*L;5M*OVU&WO]'N$ MCF0;9(I2?+D7Z#O4PY[^\U8*GL[/E3OZG/QW^G&-2_BK50Q R,=_^^:FO-1> M#PW++I&KW5[_ *0BS3.-SPH>N!@8K6V^)O\ GEHV?^VE1:?H^K::VNC"S,D7VF?]#7JOY?\ V-&JZDL&CZ>UCKEU-#)>%)KG M=\ZKCD=.WTK;V^)O^>6C?^1*RV\(ZBEE"8YK5KL7QO'!R$Z=!WH30-2MH0?; M=,/'_"6:K_G_ (#2W]\(_$T]K>:Y=V=K';QF-D;[[8&<\'KUK:*^)NT6C?\ MD2GVFC3IXDN=2NO(9)K=(]J\X88SU[470[-G-WNJ+;+$^C^(;V^NS*H%N_S! M@3SD8%;VK:16)D!/3)&*3DM+ HO6YSWA_3+O4-+L;^;6M1WR*) M&CWC:>>G3I47]HWKVWEK01E-WOBL_^Q->_P"@ M^G_@&O\ C6U96\MO:HD\WGS ?/+M"[C]!TK.*G?5G36E!K3^OP19I:2EK0Y0 MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_ !V0$! end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover
Oct. 27, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 27, 2022
Entity File Number 001-39294
Entity Registrant Name ASSERTIO HOLDINGS, INC.
Entity Central Index Key 0001808665
Entity Tax Identification Number 85-0598378
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 100 South Sanders Rd
Entity Address, Address Line Two Suite 300
Entity Address, City or Town Lake Forest
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60045
City Area Code 224
Local Phone Number 419-7106
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value
Trading Symbol ASRT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 tm2229103d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001808665 2022-10-27 2022-10-27 iso4217:USD shares iso4217:USD shares 0001808665 false 8-K 2022-10-27 ASSERTIO HOLDINGS, INC. DE 001-39294 85-0598378 100 South Sanders Rd Suite 300 Lake Forest IL 60045 224 419-7106 Common Stock, $0.0001 par value ASRT NASDAQ false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://assertiotx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2229103d1_8k.htm asrt-20221027.xsd asrt-20221027_lab.xml asrt-20221027_pre.xml tm2229103d1_ex99-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2229103d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tm2229103d1_8k.htm" ] }, "labelLink": { "local": [ "asrt-20221027_lab.xml" ] }, "presentationLink": { "local": [ "asrt-20221027_pre.xml" ] }, "schema": { "local": [ "asrt-20221027.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ASRT", "nsuri": "http://assertiotx.com/20221027", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2229103d1_8k.htm", "contextRef": "From2022-10-27to2022-10-27", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://assertiotx.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2229103d1_8k.htm", "contextRef": "From2022-10-27to2022-10-27", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://assertiotx.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001104659-22-112533-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-112533-xbrl.zip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